Ariel Investments LLC Increases Stock Position in Envista Holdings Corporation $NVST

Ariel Investments LLC boosted its position in Envista Holdings Corporation (NYSE:NVST) by 1.7% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,355,666 shares of the company’s stock after purchasing an additional 210,921 shares during the period. Envista comprises 2.7% of Ariel Investments LLC’s investment portfolio, making the stock its 11th biggest position. Ariel Investments LLC owned approximately 7.44% of Envista worth $241,430,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. US Bancorp DE raised its holdings in Envista by 22.7% in the 1st quarter. US Bancorp DE now owns 26,898 shares of the company’s stock valued at $464,000 after acquiring an additional 4,979 shares during the last quarter. Charles Schwab Investment Management Inc. grew its holdings in Envista by 2.5% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 2,375,109 shares of the company’s stock valued at $40,994,000 after buying an additional 57,478 shares during the period. Invesco Ltd. increased its stake in shares of Envista by 2.9% during the 1st quarter. Invesco Ltd. now owns 353,089 shares of the company’s stock valued at $6,094,000 after acquiring an additional 9,950 shares during the last quarter. Aigen Investment Management LP acquired a new position in shares of Envista during the 1st quarter valued at about $274,000. Finally, Nuveen LLC purchased a new position in shares of Envista during the 1st quarter worth about $5,347,000.

Analyst Ratings Changes

NVST has been the subject of a number of recent analyst reports. Zacks Research downgraded shares of Envista from a “strong-buy” rating to a “hold” rating in a report on Monday, September 15th. Barclays initiated coverage on shares of Envista in a report on Monday. They issued an “overweight” rating and a $24.00 price target on the stock. Evercore ISI reissued an “outperform” rating on shares of Envista in a research note on Friday, October 31st. Wall Street Zen raised Envista from a “buy” rating to a “strong-buy” rating in a research report on Saturday, November 1st. Finally, Mizuho set a $19.00 target price on Envista in a report on Monday, November 3rd. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, Envista has an average rating of “Hold” and a consensus price target of $21.54.

Envista Price Performance

NVST stock opened at $20.61 on Wednesday. The firm has a market cap of $3.39 billion, a P/E ratio of 229.06, a price-to-earnings-growth ratio of 0.98 and a beta of 1.02. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.02 and a current ratio of 2.37. Envista Holdings Corporation has a 1 year low of $14.22 and a 1 year high of $22.68. The stock has a 50-day simple moving average of $20.08 and a 200-day simple moving average of $20.05.

Envista (NYSE:NVST) last released its quarterly earnings results on Wednesday, October 29th. The company reported $0.32 EPS for the quarter, topping the consensus estimate of $0.27 by $0.05. The firm had revenue of $669.90 million for the quarter, compared to analyst estimates of $639.49 million. Envista had a return on equity of 5.90% and a net margin of 0.58%.Envista’s revenue for the quarter was up 11.5% on a year-over-year basis. During the same period in the previous year, the company posted $0.12 EPS. On average, equities analysts predict that Envista Holdings Corporation will post 1 earnings per share for the current fiscal year.

Envista Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.